Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT Trial
for the SELECT Trial Investigators
Medicine, Endocrinology Division
Research output
:
Contribution to journal
›
Article
›
peer-review
26
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT Trial'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Overweight or Obesity
100%
Without Diabetes
100%
Glycemia
100%
Semaglutide
100%
SELECT Trial
100%
Hemoglobin A1c (HbA1c)
85%
Diabetes
57%
Placebo
28%
Subclinical Cardiovascular Disease
28%
Cardiovascular Disease
14%
Slow Progression
14%
Plateaued
14%
Trial Participants
14%
Double-blind Trial
14%
Weight Reduction
14%
Number-needed-to-treat
14%
Glycemic Outcomes
14%
Intervention Exposure
14%
Semaglutide 2.4 Mg
14%
Glycemic Progression
14%
Subcutaneous Semaglutide
14%
Pharmacology, Toxicology and Pharmaceutical Science
Semaglutide
100%
Hemoglobin A1c
75%
Cardiovascular Disease
37%
Placebo
25%
Number Needed to Treat
12%
Neuroscience
Semaglutide
100%
Hemoglobin A1c
75%
Placebo
25%
Body Mass Index
12%